We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Semaphorins Play Regulatory Role in Nervous System Development

By Biotechdaily staff writers
Posted on 07 Aug 2003
Researchers looking at the similarities between the immune system and the nervous system have found that semaphorin 7A (Sema7A), a membrane-anchored member of the semaphorin family of guidance proteins previously known for its immunomodulatory effects, can also mediate neuronal functions. More...


Semaphorins are a family of proteins that mediate neuronal guidance by inhibiting nerve-growth cone movement. Both transmembrane and secreted proteins are included, and many domains of the proteins are highly conserved between invertebrates and vertebrates. Most are around 750 residues with a conserved "sema” domain of up to 500 extracellular residues with a single immunoglobulin C2-type domain C-terminal.

The investigators, from Johns Hopkins University (Baltimore, MD, USA), showed that unlike many other semaphorins, which act as repulsive guidance cues, Sema7A enhanced central and peripheral axon growth and was required for proper axon tract formation during embryonic development. Sema7A enhancement of axon outgrowth required integrin receptors and activation of MAPK signaling pathways.

These findings, published in the July 24, 2003, issue of Nature, define a previously unknown biological function for semaphorins. They identify an unexpected role for integrins and integrin-dependent intracellular signaling in mediating semaphorin responses and provide a framework for understanding and interfering with Sema7A function in both immune and nervous systems.

"I have been studying semaphorins for about a decade and did not expect to find any that stimulated axon growth, certainly not to the extent we saw in the lab and in mice,” said senior author Dr. Alex Kolodkin, professor of neuroscience at Johns Hopkins University. "Now we need to figure out how semaphorins balance their repulsive and attractive effects.”




Related Links:
Johns Hopkins University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.